human | Q5 |
P496 | ORCID iD | 0000-0003-1808-6431 |
P1053 | ResearcherID | E-7768-2012 |
P735 | given name | Karen | Q1221747 |
Karen | Q1221747 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q45070596 | 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea |
Q52763778 | 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. |
Q50358119 | 768Host Gene Polymorphisms and Susceptibility to Viral Enteropathogens in Children Living in The Gambia and Kenya. |
Q57929967 | A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge |
Q98718889 | A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children |
Q62486358 | A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper |
Q45857235 | A Voluntary Serosurvey and Behavioral Risk Assessment for Human Immunodeficiency Virus Infection Among College Students |
Q54158784 | A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. |
Q28767862 | A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology |
Q54260897 | A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation. |
Q41986831 | A randomized, placebo-controlled, double-blind Phase 2 trial comparing the reactogenicity and immunogenicity of a single ≥2x108 colony forming units [cfu] standard-dose versus a ≥2x109 cfu high-dose of CVD 103-HgR live attenuated oral cholera vaccin |
Q26851900 | A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium |
Q46339112 | A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali |
Q71335481 | A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B streptococcus type-specific antibodies in humans |
Q36551627 | A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali |
Q39146474 | Acute diarrhea in Baltimore children attending an outpatient clinic. |
Q33178756 | Adeno-associated virus and development of cervical neoplasia |
Q39373037 | Aeromonas-Associated Diarrhea in Children Under 5 Years: The GEMS Experience |
Q38645960 | Animal-related factors associated with moderate-to-severe diarrhea in children younger than five years in western Kenya: A matched case-control study |
Q93006114 | Antibiotic Treatment of Nonsevere Pneumonia With Fast Breathing-Is the Pendulum Swinging? |
Q47561555 | Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals |
Q37120727 | Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates |
Q34809879 | Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates. |
Q34999911 | Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy. |
Q35065640 | Assessment of the epidemiology and burden of measles in Southern Mozambique |
Q39146467 | Assessment of the prevalence and risk factors for human immunodeficiency virus type 1 (HIV-1) infection among college students using three survey methods |
Q30278777 | Association Between Shigella Infection and Diarrhea Varies Based on Location and Age of Children |
Q30411937 | Association between moderate-to-severe diarrhea in young children in the global enteric multicenter study (GEMS) and types of handwashing materials used by caretakers in Mirzapur, Bangladesh |
Q56917368 | Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study |
Q101223296 | Associations between Household-Level Exposures and All-Cause Diarrhea and Pathogen-Specific Enteric Infections in Children Enrolled in Five Sentinel Surveillance Studies |
Q44280800 | B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals |
Q30299938 | Bacterial Factors Associated with Lethal Outcome of Enteropathogenic Escherichia coli Infection: Genomic Case-Control Studies |
Q33737011 | Bayesian Estimation of Pneumonia Etiology: Epidemiologic Considerations and Applications to the Pneumonia Etiology Research for Child Health Study |
Q34345075 | Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study |
Q30384769 | Burden of disease from cryptosporidiosis. |
Q40507046 | Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine |
Q92668185 | Campylobacter Abundance in Breastfed Infants and Identification of a New Species in the Global Enterics Multicenter Study |
Q50049631 | Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series |
Q44925924 | Carriage of Citrobacter diversus among young children in Baltimore |
Q41582033 | Case/control studies with follow-up: Constructing the source population to estimate effects of risk factors on development, disease, and survival |
Q92230187 | Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902 |
Q47244865 | Characterization of Invasive Salmonella Serogroup C1 Infections in Mali |
Q56952384 | Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study |
Q74519686 | Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-mont |
Q30366806 | Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children. |
Q40436195 | Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine |
Q93075052 | Clinical endpoints for efficacy studies |
Q59135204 | Clinical features, risk factors, and impact of antibiotic treatment of diarrhea caused by Shigella in children less than 5 years in Manhiça District, rural Mozambique |
Q100508795 | Clinical predictors for etiology of acute diarrhea in children in resource-limited settings |
Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
Q56342019 | Clinical, environmental, and behavioral characteristics associated with Cryptosporidium infection among children with moderate-to-severe diarrhea in rural western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS) |
Q34714718 | Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A |
Q56951717 | Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii |
Q61806436 | Colonization factors among enterotoxigenic Escherichia coli isolates from children with moderate-to-severe diarrhea and from matched controls in the Global Enteric Multicenter Study (GEMS) |
Q38982022 | Community-acquired diarrhoea in a world with rotavirus vaccine: a glimpse into the future |
Q41122192 | Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects |
Q91801435 | Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints |
Q91801457 | Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies |
Q44713046 | Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection |
Q92203588 | Cryptosporidium infection in rural Gambian children: Epidemiology and risk factors |
Q30578108 | Data management and other logistical challenges for the GEMS: the data coordinating center perspective |
Q39146446 | Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. |
Q56920752 | Density of Upper Respiratory Colonization With Streptococcus pneumoniae and Its Role in the Diagnosis of Pneumococcal Pneumonia Among Children Aged <5 Years in the PERCH Study |
Q64378769 | Detection by immune electron microscopy of 27-nm viral particles associated with community-acquired diarrhea in children |
Q56940001 | Detection of Pneumococcal DNA in Blood by Polymerase Chain Reaction for Diagnosing Pneumococcal Pneumonia in Young Children From Low- and Middle-Income Countries |
Q36896687 | Detection of genital human papillomavirus and associated cytological abnormalities among college women |
Q37108048 | Determinants of health care seeking for diarrheal illness in young children in urban slums of Kolkata, India |
Q36412073 | Determinants of household costs associated with childhood diarrhea in 3 South Asian settings |
Q91447492 | Determinants of linear growth faltering among children with moderate-to-severe diarrhea in the Global Enteric Multicenter Study |
Q37223214 | Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers |
Q30423347 | Diagnostic microbiologic methods in the GEMS-1 case/control study |
Q30412052 | Diarrhea in young children from low-income countries leads to large-scale alterations in intestinal microbiota composition |
Q35606839 | Diarrheal Disease in Rural Mozambique: Burden, Risk Factors and Etiology of Diarrheal Disease among Children Aged 0-59 Months Seeking Care at Health Facilities |
Q42561946 | Diarrheal disease constitutes one of the top two causes of mortality among young children in developing countries. Preface |
Q72743044 | Diarrheal morbidity during the first 2 years of life among HIV-infected infants |
Q64135948 | Diarrhoea, enteric pathogen detection and nutritional indicators among controls in the Global Enteric Multicenter Study, Kenya site: an opportunity to understand reference populations in case-control studies of diarrhoea |
Q92176153 | Diarrhoeal disease and subsequent risk of death in infants and children residing in low-income and middle-income countries: analysis of the GEMS case-control study and 12-month GEMS-1A follow-on study |
Q98774627 | Digital auscultation in PERCH: Associations with chest radiography and pneumonia mortality in children |
Q45072369 | Direct Detection of Shigella in Stool Specimens by Use of a Metagenomic Approach |
Q57819804 | Dynamics of antimicrobial resistance in intestinal Escherichia coli from children in community settings in South Asia and sub-Saharan Africa |
Q30203099 | Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial |
Q104619028 | Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine |
Q46793235 | Efficacy of the oral pentavalent rotavirus vaccine in Mali |
Q38517040 | Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings |
Q40435116 | Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique |
Q91954422 | Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus Infections in Newborns in Bamako, Mali |
Q30276185 | Epidemiology, Seasonality and Factors Associated with Rotavirus Infection among Children with Moderate-to-Severe Diarrhea in Rural Western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS) |
Q41367176 | Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements |
Q56913512 | Evaluation of Pneumococcal Load in Blood by Polymerase Chain Reaction for the Diagnosis of Pneumococcal Pneumonia in Young Children in the PERCH Study |
Q53829816 | Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants. |
Q40687041 | Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2 |
Q30276039 | Evolution of atypical enteropathogenic E. coli by repeated acquisition of LEE pathogenicity island variants |
Q36412068 | Exploring household economic impacts of childhood diarrheal illnesses in 3 African settings |
Q40118345 | Factors Associated with the Duration of Moderate-to-Severe Diarrhea among Children in Rural Western Kenya Enrolled in the Global Enteric Multicenter Study, 2008-2012. |
Q102062623 | Factors associated with typical enteropathogenic Escherichia coli infection among children <5 years old with moderate-to-severe diarrhoea in rural western Kenya, 2008-2012 |
Q37633069 | Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study |
Q30428800 | Genomic characterization of enteroaggregative Escherichia coli from children in Mali |
Q30276038 | Genomic diversity of EPEC associated with clinical presentations of differing severity |
Q35690664 | Genotypic analysis of invasive Streptococcus pneumoniae from Mali, Africa, by semiautomated repetitive-element PCR and pulsed-field gel electrophoresis |
Q33749510 | Global burden of Shigella infections: implications for vaccine development and implementation of control strategies |
Q103039138 | Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study |
Q50057444 | Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years |
Q38687853 | Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study |
Q34068059 | Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans |
Q47701344 | Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection. |
Q37108012 | Health Care Utilization and Attitudes Survey: understanding diarrheal disease in rural Gambia |
Q90621870 | Health and Demographic Surveillance Systems Within the Child Health and Mortality Prevention Surveillance Network |
Q37108025 | Health care seeking for childhood diarrhea in developing countries: evidence from seven sites in Africa and Asia |
Q37108043 | Health care use patterns for diarrhea in children in low-income periurban communities of Karachi, Pakistan |
Q37108039 | Health care utilization and attitudes survey in cases of moderate-to-severe diarrhea among children ages 0-59 months in the District of Manhica, southern Mozambique |
Q37108020 | Health care-seeking behavior during childhood diarrheal illness: results of health care utilization and attitudes surveys of caretakers in western Kenya, 2007-2010 |
Q37108052 | Health care-seeking behavior for childhood diarrhea in Mirzapur, rural Bangladesh |
Q30457238 | High genotypic diversity among rotavirus strains infecting Gambian children |
Q35741958 | Higher antigen content improves the immune response to 2009 H1N1 influenza vaccine in HIV-infected adults: a randomized clinical trial |
Q68972420 | Histoplasma duboisii infection in a Liberian girl |
Q30418588 | Housefly population density correlates with shigellosis among children in Mirzapur, Bangladesh: a time series analysis |
Q64081813 | Household Costs of Diarrhea by Etiology in 7 Countries, The Global Enterics Mulitcenter Study (GEMS) |
Q92261979 | How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella? |
Q39146451 | Human challenge studies with infectious agents |
Q33541011 | Identification by PCR of non-typhoidal Salmonella enterica serovars associated with invasive infections among febrile patients in Mali |
Q40095911 | Identification of immune correlates of protection in Shigella infection by application of machine learning |
Q30419062 | Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons |
Q41059635 | Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect |
Q98296767 | Incidence and etiology of clinically-attended, antibiotic-treated diarrhea among children under five years of age in low- and middle-income countries: Evidence from the Global Enteric Multicenter Study |
Q96613072 | Initial findings from a novel population-based child mortality surveillance approach: a descriptive study |
Q30376669 | Introduction to the Epidemiologic Considerations, Analytic Methods, and Foundational Results From the Pneumonia Etiology Research for Child Health Study |
Q40378524 | Invasive non-typhoidal Salmonella in Mozambican children |
Q39689520 | Invasive pneumococcal infections among hospitalized children in Bamako, Mali |
Q56888929 | Is Higher Viral Load in the Upper Respiratory Tract Associated With Severe Pneumonia? Findings From the PERCH Study |
Q67940117 | Lack of association between Clostridium difficile toxin and diarrhea in infants |
Q56398095 | Limited Utility of Polymerase Chain Reaction in Induced Sputum Specimens for Determining the Causes of Childhood Pneumonia in Resource-Poor Settings: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study |
Q39162539 | MRSA with progression from otitis media and sphenoid sinusitis to clival osteomyelitis, pachymeningitis and abducens nerve palsy in an immunocompetent 10-year-old patient |
Q61453230 | Maternal Influenza Vaccination and the Risk of Laboratory-Confirmed Influenza Among Household Contacts Under the Age of Five in Mali |
Q37176794 | Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial |
Q62486723 | Measles-specific neutralizing antibodies in rural Mozambique: seroprevalence and presence in breast milk |
Q80186096 | Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys |
Q30408229 | Microbiota that affect risk for shigellosis in children in low-income countries |
Q56398065 | Microscopic Analysis and Quality Assessment of Induced Sputum From Children With Pneumonia in the PERCH Study |
Q43405880 | Molecular epidemiology of rotavirus infection in a room for convalescing newborns |
Q57927103 | Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016 |
Q55251334 | Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study. |
Q95578764 | Mortality Surveillance Methods to Identify and Characterize Deaths in Child Health and Mortality Prevention Surveillance Network Sites |
Q90764146 | Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units |
Q37642506 | New and candidate vaccines for gastrointestinal infections |
Q91597850 | Next-generation rotavirus vaccines: important progress but work still to be done |
Q74637084 | Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults |
Q90621862 | Overview and Development of the Child Health and Mortality Prevention Surveillance Determination of Cause of Death (DeCoDe) Process and DeCoDe Diagnosis Standards |
Q34784851 | Overview of vaccines and immunisation |
Q36672996 | PCR method to identify Salmonella enterica serovars Typhi, Paratyphi A, and Paratyphi B among Salmonella Isolates from the blood of patients with clinical enteric fever |
Q30381280 | Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant |
Q37410317 | Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study |
Q30224646 | Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009. |
Q34003500 | Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers |
Q34120926 | Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults |
Q55260950 | Pneumonia mortality and healthcare utilization in young children in rural Bangladesh: a prospective verbal autopsy study. |
Q40258664 | Potential coverage of a multivalent M protein-based group A streptococcal vaccine |
Q37233946 | Predictors of diarrheal mortality and patterns of caregiver health seeking behavior in in Karachi, Pakistan |
Q35228978 | Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women |
Q41480678 | Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain |
Q37105553 | Progress and pitfalls in Shigella vaccine research |
Q35856273 | Progress in group A streptococcal vaccine development |
Q37089561 | Quality of piped and stored water in households with children under five years of age enrolled in the Mali site of the Global Enteric Multi-Center Study (GEMS). |
Q30416070 | Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries |
Q34002698 | Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination |
Q64112196 | Risk factors for death among children 0-59 months of age with moderate-to-severe diarrhea in Manhiça district, southern Mozambique |
Q36518775 | Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules |
Q36953080 | Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial |
Q81445405 | Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media |
Q38380006 | Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial |
Q56925522 | Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial |
Q34006013 | Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults |
Q34007563 | Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection |
Q92375588 | Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents |
Q56398139 | Safety of Induced Sputum Collection in Children Hospitalized With Severe or Very Severe Pneumonia |
Q40573590 | Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children |
Q30204578 | Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant |
Q36945836 | Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. |
Q35528270 | Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. |
Q33299673 | Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults |
Q43536234 | Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector |
Q30276876 | Sanitation and Hygiene-Specific Risk Factors for Moderate-to-Severe Diarrhea in Young Children in the Global Enteric Multicenter Study, 2007-2011: Case-Control Study |
Q30543267 | Seeking care for pediatric diarrheal illness from traditional healers in Bamako, Mali |
Q35228223 | Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein. |
Q37477191 | Shigella Vaccine Development: Finding the Path of Least Resistance |
Q36920244 | Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. |
Q34003433 | Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans |
Q50045307 | Shigella infection in children and adults: a formidable foe. |
Q34202171 | Shigella isolates from the global enteric multicenter study inform vaccine development |
Q56383780 | Shigellosis |
Q56952891 | Should Controls With Respiratory Symptoms Be Excluded From Case-Control Studies of Pneumonia Etiology? Reflections From the PERCH Study |
Q30423340 | Some epidemiologic, clinical, microbiologic, and organizational assumptions that influenced the design and performance of the Global Enteric Multicenter Study (GEMS). |
Q57231758 | Standardization of Clinical Assessment and Sample Collection Across All PERCH Study Sites |
Q33737034 | Standardization of Laboratory Methods for the PERCH Study |
Q36412081 | Statistical methods in the Global Enteric Multicenter Study (GEMS). |
Q46175420 | Strengthening immunization in a West African country: Mali. |
Q30301331 | Streptococcal pharyngitis in schoolchildren in Bamako, Mali |
Q38648228 | Summary of workshop "global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques". |
Q98160158 | Surveillance for Invasive Salmonella Disease in Bamako, Mali, From 2002 to 2018 |
Q30414062 | Survey of culture, goldengate assay, universal biosensor assay, and 16S rRNA Gene sequencing as alternative methods of bacterial pathogen detection |
Q52657631 | T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. |
Q97870021 | The Aetiology of pneumonia from analysis of Lung aspirate and Pleural fluid samples: Findings from the PERCH study |
Q39146427 | The Burden and Etiology of Diarrheal Illness in Developing Countries |
Q30276745 | The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS) |
Q56398077 | The Diagnostic Utility of Induced Sputum Microscopy and Culture in Childhood Pneumonia |
Q56991084 | The Effect of Antibiotic Exposure and Specimen Volume on the Detection of Bacterial Pathogens in Children With Pneumonia |
Q36412034 | The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study |
Q30423344 | The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis |
Q28731424 | The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study |
Q30352868 | The Relationship Between Distance to Water Source and Moderate-to-Severe Diarrhea in the Global Enterics Multi-Center Study in Kenya, 2008-2011 |
Q57275157 | The Typhoid Vaccine Acceleration Consortium (TyVAC): Vaccine effectiveness study designs: Accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26–27 October 2016, |
Q35826028 | The causes of hospital admission and death among children in Bamako, Mali |
Q100522539 | The clinical presentation of culture-positive and culture-negative, qPCR-attributable shigellosis in the Global Enteric Multicenter Study and derivation of a Shigella severity score: implications for pediatric Shigella vaccine trials |
Q92937781 | The effect of acute malnutrition on enteric pathogens, moderate-to-severe diarrhoea, and associated mortality in the Global Enteric Multicenter Study cohort: a post-hoc analysis |
Q46705920 | The effect of costs on Kenyan households' demand for medical care: why time and distance matter |
Q68049346 | The frequency of astrovirus as a cause of diarrhea in Baltimore children |
Q64114155 | The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicent |
Q64124048 | The predictive performance of a pneumonia severity score in HIV-negative children presenting to hospital in seven low and middle-income countries |
Q39146442 | The prospect of vaccination against group A beta-hemolytic streptococci |
Q58144447 | The role of HIV infection in the etiology and epidemiology of diarrheal disease among children aged 0-59 months in Manhiça District, Rural Mozambique |
Q92638317 | The seasonality of diarrheal pathogens: A retrospective study of seven sites over three years |
Q62486369 | Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi |
Q30275836 | Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study |
Q73408633 | Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111 |
Q59355070 | Water, Sanitation, and Hygiene Characteristics among HIV-Positive Households Participating in the Global Enteric Multicenter Study in Rural Western Kenya, 2008-2012 |
Search more.